People Alex Garanto

Contact

Alex Garanto PhD

+31 24 361 41 07
contact

Alex Garanto researcher

Currently, I am starting my own group focused on on the design and assessment of new therapeutic approaches for inherited retinal disorders.

read more

Alex Garanto researcher

I started my PhD project in the field of Genetics after finishing my studies in Biology at the University of Barcelona. During my PhD, I focused on elucidating the function of CERKL, an inherited retinal dystrophy gene, as well as the characterization of a knockout mouse model for this gene. After my PhD, I studied the contribution of Ubiquitin and Sumo signalling in the determination of photoreceptor cell fate at the University of Barcelona. In October 2012, I joined the group of Dr. Rob Collin at the Department of Human Genetics of the Radboudumc to investigate a promising antisense oligonucleotide (AON)-based therapy for one of the most recurrent mutations in CEP290 gene causing Leber congenital amaurosis. In the last years, I have been involved in expanding the use of these molecules to other eye diseases. Currently, I am starting my own group focused on on the design and assessment of new therapeutic approaches for inherited retinal disorders.

Field of study

Human Genetics

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more